Q3 2017 Holdings
Filed 2017-11-14 | 30 holdings | $62.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $62.1M | 600,000 | 99.4% |
| Avexis Inc | COM | 05366U100 | $77.4K | 800,000 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $41.2K | 500,000 | 0.1% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $40.7K | 2,200,000 | 0.1% |
| Medicines Company | COM | 584688105 | $33.3K | 900,000 | 0.1% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $25.1K | 500,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $25.0K | 1,250,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $17.4K | 250,000 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $15.7K | 629,179 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $12.6K | 844,789 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $12.1K | 1,037,994 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $12.0K | 100,000 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $9.3K | 267,500 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $8.2K | 1,012,986 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $7.0K | 200,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.2K | 200,000 | 0.0% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $5.9K | 856,900 | 0.0% |
| GTX Inc del | COM NEW | 40052B207 | $4.8K | 565,291 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $4.4K | 312,500 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $3.4K | 500,000 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $2.7K | 2,197,802 | 0.0% |
| Belleropon Therapeutics Inc(BLPHEUR) | COM | 078771102 | $2.6K | 1,857,143 | 0.0% |
| Aradigm Corp(ARDMEUR) | COM PAR | 038505400 | $2.1K | 500,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $2.0K | 1,025,000 | 0.0% |
| Barclays BK PLC | IPATH S&P 500 VIX | 06746L422 | $2.0K | 50,000 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $1.5K | 138,331 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.2K | 100,000 | 0.0% |
| Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | $710 | 86,710 | 0.0% |
| Onconova Therapeutics Inc | *W EXP 07/07/202 | 68232V116 | $528 | 308,793 | 0.0% |
| Onconova Therapeutics Inc | COM NEW | 68232V306 | $92 | 241,644 | 0.0% |